Bourgeon Capital Management’s Eli Lilly LLY Stock Holding History

Bourgeon Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21.4M	Sell	23,299 -219	-0.9%	-$222K	3.71%	3
2025 Q4	$25.3M	Sell	23,518 -29	-0.1%	-$27.7K	4.09%	3
2025 Q3	$18M	Buy	23,547 +10,676	+83%	+$7.94M	3.24%	4
2025 Q2	$10M	Buy	12,871 +11,959	+1,311%	+$9.29M	1.98%	24
2025 Q1	$753K	Sell	912 -487	-35%	-$405K	0.16%	66
2024 Q4	$1.08M	Buy	+1,399	New	+$1.16M	0.2%	61
2020 Q4	–	Sell	-5	Closed	-$1K	–	298
2020 Q3	$1K	Buy	+5	New	+$774	﹤0.01%	282

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bourgeon Capital Management's LLY Position: Q1 2026 in Review

Bourgeon Capital Management reduced its Eli Lilly (LLY) stake by 0.93% in Q1 2026, selling an estimated $222K and leaving 23,299 shares worth $21.4M. The position accounts for 3.71% of the portfolio, ranked #3.

Bourgeon Capital Management first reported a position in LLY in Q3 2020 and has held it in 7 quarters since. The position peaked at $25.3M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Bourgeon Capital Management held 23,299 shares of Eli Lilly worth $21.4M as of Q1 2026.
Bourgeon Capital Management sold 219 Eli Lilly shares in Q1 2026, an estimated $222K.
Eli Lilly made up 3.71% of Bourgeon Capital Management's portfolio in Q1 2026, its #3 holding.
Bourgeon Capital Management first reported a position in Eli Lilly in Q3 2020 and has held it in 7 quarters since.
Bourgeon Capital Management's Eli Lilly position peaked at $25.3M in Q4 2025.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bourgeon Capital Management's 13F filing for Q1 2026, filed 13 Apr 2026.